KR20210153178A - Composition for promoting absorption of collagen and synthesis of collagen - Google Patents
Composition for promoting absorption of collagen and synthesis of collagen Download PDFInfo
- Publication number
- KR20210153178A KR20210153178A KR1020200069596A KR20200069596A KR20210153178A KR 20210153178 A KR20210153178 A KR 20210153178A KR 1020200069596 A KR1020200069596 A KR 1020200069596A KR 20200069596 A KR20200069596 A KR 20200069596A KR 20210153178 A KR20210153178 A KR 20210153178A
- Authority
- KR
- South Korea
- Prior art keywords
- collagen
- weight
- concentrate
- parts
- composition
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 122
- 108010035532 Collagen Proteins 0.000 title claims abstract description 122
- 229920001436 collagen Polymers 0.000 title claims abstract description 122
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 230000015572 biosynthetic process Effects 0.000 title abstract description 12
- 238000003786 synthesis reaction Methods 0.000 title abstract description 12
- 238000010521 absorption reaction Methods 0.000 title abstract description 11
- 230000001737 promoting effect Effects 0.000 title abstract description 6
- 239000012141 concentrate Substances 0.000 claims abstract description 64
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 33
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004386 Erythritol Substances 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000019414 erythritol Nutrition 0.000 claims abstract description 19
- 229940009714 erythritol Drugs 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 19
- 229960003080 taurine Drugs 0.000 claims abstract description 18
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 17
- 229930064664 L-arginine Natural products 0.000 claims abstract description 16
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 16
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 16
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 16
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 15
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 15
- 235000020776 essential amino acid Nutrition 0.000 claims abstract description 15
- 239000003797 essential amino acid Substances 0.000 claims abstract description 15
- 239000008213 purified water Substances 0.000 claims abstract description 15
- 239000001509 sodium citrate Substances 0.000 claims abstract description 15
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 14
- 108090000790 Enzymes Proteins 0.000 claims abstract description 14
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 14
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 14
- 241000219991 Lythraceae Species 0.000 claims description 31
- 235000021537 Beetroot Nutrition 0.000 claims description 17
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 15
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 235000019634 flavors Nutrition 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 14
- 229940038773 trisodium citrate Drugs 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 3
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 claims description 2
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 8
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 244000078534 Vaccinium myrtillus Species 0.000 abstract description 4
- 235000016623 Fragaria vesca Nutrition 0.000 abstract description 2
- 240000009088 Fragaria x ananassa Species 0.000 abstract description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 abstract description 2
- 240000001890 Ribes hudsonianum Species 0.000 abstract description 2
- 235000016954 Ribes hudsonianum Nutrition 0.000 abstract description 2
- 235000001466 Ribes nigrum Nutrition 0.000 abstract description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 abstract description 2
- 240000007651 Rubus glaucus Species 0.000 abstract description 2
- 235000011034 Rubus glaucus Nutrition 0.000 abstract description 2
- 235000009122 Rubus idaeus Nutrition 0.000 abstract description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 abstract description 2
- 240000001717 Vaccinium macrocarpon Species 0.000 abstract description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 abstract description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 abstract description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 abstract description 2
- 235000003650 acai Nutrition 0.000 abstract description 2
- 235000021029 blackberry Nutrition 0.000 abstract description 2
- 235000021014 blueberries Nutrition 0.000 abstract description 2
- 235000004634 cranberry Nutrition 0.000 abstract description 2
- 244000294611 Punica granatum Species 0.000 abstract 2
- 235000021535 Beta vulgaris subsp. vulgaris Nutrition 0.000 abstract 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 abstract 1
- 239000010404 Scutellaria baicalensis extract Substances 0.000 abstract 1
- 239000003205 fragrance Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 23
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- -1 becacarotene Chemical compound 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229960004543 anhydrous citric acid Drugs 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 229960002591 hydroxyproline Drugs 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 235000007686 potassium Nutrition 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 235000019614 sour taste Nutrition 0.000 description 3
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 108010077465 Tropocollagen Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000003832 immune regulation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- GMPYNOTVKNXELU-UHFFFAOYSA-N 1-bromoethanesulfonic acid Chemical class CC(Br)S(O)(=O)=O GMPYNOTVKNXELU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000605059 Bacteroidetes Species 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 241000723128 Moniliella pollinis Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 241000544066 Stevia Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000908249 Trichosporonoides Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000000842 betacyanins Nutrition 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000007691 collagen metabolic process Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0606—Arginine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5422—Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/6402—Erythritol
Abstract
Description
본 발명은 체내로의 콜라겐 흡수 및 체내에서 콜라겐 합성을 촉진하는 조성물에 관한 것이다.The present invention relates to a composition that promotes collagen absorption into the body and collagen synthesis in the body.
콜라겐(Collagen)은 경단백질 또는 교원질(膠原質)이라고도 하며 무척추동물이나 척추동물 등의 다세포동물에 널리 분포하며 양적으로도 가장 많이 발견되는 경단백질이다. 포유류에서는 전체 단백질의 약 1/3을 차지하며 동물의 결합조직을 구성하고 있는 주요한 섬유 모양의 장력이 매우 강한 경단백질로서 힘줄이나 인대에서 힘을 손실 없이 전달한다.Collagen, also called hard protein or collagen, is widely distributed in multicellular animals such as invertebrates and vertebrates and is the most quantitatively found hard protein. In mammals, it accounts for about 1/3 of the total protein and is a hard protein with very strong fibrous tension, which constitutes the connective tissue of animals, and transmits force from tendons or ligaments without loss.
콜라겐의 기본적 구조단위는 분자량 약 30만의 트로포콜라겐(母膠原質)이다. 이 분자는 3가닥의 폴리펩티드사슬이 오른쪽 꼬임의 삼중나선구조로 되어 있다. 트로포콜라겐분자는 회합하여 콜라겐 섬유(교원섬유)를 형성하는데 각 분자는 축 방향으로 1/4 씩 어긋나게 배열되어 64 ㎚ 간격의 독특한 줄무늬를 형성하면서 동물의 생장과 함께 분자 사이에 다리 걸친 구조가 생겨 불용성으로 된다. 그러나 콜라겐을 열수나 희산 또는 묽은 알칼리에서 오래 끓이면 물에 녹는 유도단백질 젤라틴으로 변한다.The basic structural unit of collagen is tropocollagen with a molecular weight of about 300,000. This molecule has a triple helix structure in which the three-stranded polypeptide chain is right-twisted. Tropocollagen molecules associate to form collagen fibers (collagen fibers), and each molecule is arranged one-quarter shift in the axial direction to form unique stripes at 64 nm intervals. becomes insoluble. However, if collagen is boiled for a long time in hot water, dilute acid, or dilute alkali, it is converted into water-soluble inducible protein gelatin.
콜라겐의 주된 기능은 피부의 견고성, 조직의 저항력과 결합력, 세포접착의 지탱 등이 알려져 있다. 이러한 콜라겐은 고령화 및 자외선 조사에 의한 광노화로 인하여 피부의 두께가 얇아지고 이러한 현상은 피부의 주름 형성에 밀접한 관련이 있다고 알려져 있다.It is known that the main function of collagen is the firmness of the skin, the resistance and bonding of tissues, and the support of cell adhesion. Such collagen is known to be closely related to the formation of wrinkles in the skin because the thickness of the skin becomes thinner due to aging and photoaging caused by UV irradiation.
소득 수준이 높아지고 노령화 사회로 접어 들면서 피부 노화에 대한 광범위한 연구가 진전되어 콜라겐의 피부에 대한 기능이 밝혀지고 있다. 그 중에서 콜라겐의 합성 촉진에 의해 콜라겐 대사가 활발해지면 진피 메트릭스의 성분이 증가되어 주름개선, 탄력증진, 피부강화 및 상처치유의 효과를 기대할 수 있다는 주장에 따라 콜라겐합성 촉진물질인 레티논산(retinoic acid), TGF(transforming growth factor), 동물유래 태반(placenta), 베투린산(betulinic acid), 클로렐라추출물 등을 피부강화용 화장료 조성물로 사용한 제품들이 많이 출시되었으나 크게 각광을 받지 못하였다.As income levels rise and we enter an aging society, extensive research on skin aging has progressed, revealing the function of collagen on the skin. Among them, retinoic acid (retinoic acid), a collagen synthesis promoting substance, can be expected to have the effects of wrinkle improvement, elasticity enhancement, skin strengthening and wound healing by increasing the components of the dermal matrix when collagen metabolism is activated by promoting collagen synthesis. ), transforming growth factor (TGF), animal-derived placenta, betulinic acid, chlorella extract, etc. have been released as cosmetic compositions for skin strengthening, but many products have not received much attention.
또한 콜라겐을 피부 보호용 화장품 조성물로 하는 콜라겐을 배합한 제품들이 다수 판매되고 있으나, 피부 표면에 도포하는 화장품은 고분자인 콜라겐의 경피 흡수가 어려워 피부의 보습작용을 기대하기 어렵다는 지적이 있다.In addition, there are many products that contain collagen as a cosmetic composition for skin protection, but it is pointed out that cosmetics applied to the skin surface have difficulty in dermal absorption of collagen, which is a polymer, so that it is difficult to expect a moisturizing effect on the skin.
최근 들어 콜라겐 펩타이드는 건강식품, 외과용 또는 안과용 치료제 또는 화장품용 첨가제로 사용이 증가되고 있는 추세이다. 한편 이들 콜라겐 펩타이드는 식품학적, 약제학적 및 화장품학적으로 볼 때 제품의 안정성과 피부 또는 체내 흡수율이 중요시되고 있다.Recently, the use of collagen peptides as health food, surgical or ophthalmic treatment or cosmetic additive is increasing. On the other hand, from a food, pharmaceutical, and cosmetic point of view, the stability of the product and absorption rate into the skin or body are important for these collagen peptides.
본 발명은 식품, 화장품 또는 사료 등에 사용할 수 있는 콜라겐 조성물로, 콜라겐의 체내 흡수와 체내 합성에 효과적일 뿐 아니라, 보존성 또는 안정성이 좋고, 식감이 좋은 콜라겐의 흡수 및 콜라겐의 합성을 촉진하는 조성물을 제공한다.The present invention is a collagen composition that can be used in food, cosmetics, or feed, and is effective for the absorption and synthesis of collagen in the body, as well as a composition that promotes the absorption and synthesis of collagen with good preservation or stability and good texture. to provide.
본 발명의 콜라겐 조성물은, 정제수, 콜라겐, 히알루론산, 레드비트농축액, 아세로라농축액, 타우린, 필수아미노산, L-아르기닌(L-Arginine), 복합황금추출물, 에리스리톨, 천연석류향, 효소처리스테비아, 무수구연산(Citric Acid Anhydrous), 구연산삼나트륨, 석류농축액, 세븐베리농축액을 포함한다.The collagen composition of the present invention is purified water, collagen, hyaluronic acid, red beet concentrate, acerola concentrate, taurine, essential amino acids, L-arginine, complex golden extract, erythritol, natural pomegranate flavor, enzyme-treated stevia, citric anhydride (Citric Acid Anhydrous), trisodium citrate, pomegranate concentrate, and sevenberry concentrate.
상기 콜라겐 조성물은 정제수 50 내지 52 중량부, 콜라겐 26 내지 27 중량부, 히알루론산 0.4 내지 0.5중량부, 레드비트농축액 0.6 내지 0.7 중량부, 아세로라농축액 1.18 내지 1.22 중량부, 타우린 1.6 내지 1.7 중량부, 필수아미노산 0.09 내지 0.11 중량부, L-아르기닌 0.035 내지0.039 중량부, 복합황금추출물 0.19 내지 0.21 중량부, 에리스리톨 10.8 내지 11.2 중량부, 천연석류향 0.5 내지 0.7 중량부, 효소처리스테비아 0.198 내지 0.022 중량부, 무수구연산(Citric Acid Anhydrous) 1.1 내지 1.3, 구연산삼나트륨 0.08 내지 0.12 중량부, 석류농축액 2.9 내지 3.1 중량부, 세븐베리농축액 1.9 내지 2.1 중량부를 포함할 수 있다.The collagen composition comprises 50 to 52 parts by weight of purified water, 26 to 27 parts by weight of collagen, 0.4 to 0.5 parts by weight of hyaluronic acid, 0.6 to 0.7 parts by weight of red beet concentrate, 1.18 to 1.22 parts by weight of acerola concentrate, 1.6 to 1.7 parts by weight of taurine, Essential amino acid 0.09 to 0.11 parts by weight, L-arginine 0.035 to 0.039 parts by weight, complex golden extract 0.19 to 0.21 parts by weight, erythritol 10.8 to 11.2 parts by weight, natural pomegranate flavor 0.5 to 0.7 parts by weight, enzyme-treated stevia 0.198 to 0.022 parts by weight, It may contain 1.1 to 1.3 parts by weight of Citric Acid Anhydrous, 0.08 to 0.12 parts by weight of trisodium citrate, 2.9 to 3.1 parts by weight of pomegranate concentrate, and 1.9 to 2.1 parts by weight of sevenberry concentrate.
상기 콜라겐은, 크기가 1nm 내지 10nm로 나노화되며, 분자량이 250 Da 내지 650 Da인 콜라겐 펩타이드인 것을 특징으로 할 수 있다.The collagen is nanosized to have a size of 1 nm to 10 nm and may be characterized as a collagen peptide having a molecular weight of 250 Da to 650 Da.
상기 콜라겐은, 크기가 6nm 내지 8nm이고 평균분자량이 500 Da이고 콜라겐 펩타이드인 것을 특징으로 할 수 있다.The collagen has a size of 6 nm to 8 nm, an average molecular weight of 500 Da, and may be characterized as a collagen peptide.
상기 콜라겐은 KTTKS, GHK, AHK 및 이들의 혼합물 중 어느 하나 이상일 수 있다.The collagen may be any one or more of KTTKS, GHK, AHK, and mixtures thereof.
본 발명의 콜라겐의 흡수 및 콜라겐의 합성을 촉진하는 조성물은 콜라겐의 체내 흡수와 체내 합성에 효과적일 뿐 아니라, 보존성 또는 안정성이 좋고, 식감이 좋다. 이에 따라 피부 노화를 억제하고, 피부 주름을 개선할 수 있으며, 피부의 수분 함유량을 높여 피부 보습성을 개선시킬 수 있다.The composition for promoting the absorption and synthesis of collagen of the present invention is not only effective for the absorption and synthesis of collagen in the body, but also has good preservation or stability, and has a good texture. Accordingly, skin aging can be suppressed, skin wrinkles can be improved, and skin moisture content can be improved by increasing the moisture content of the skin.
본 발명의 조성물은 비타민, 철분, 칼륨, 섬유소질 및 베타시아닌 등이 풍부해 빈혈 예방에 효과적이고, 혈압을 낮추는 효과가 있다.The composition of the present invention is effective in preventing anemia and lowering blood pressure because it is rich in vitamins, iron, potassium, fiber and beta-cyanin.
본 발명의 조성물은 아스코르빈산(ascorbic acid), 베카카로틴, 니아신, 티아민, 리보플라민, 플라노보이드 등의 각종 미네랄이 풍부하여 알레르기 비염이나 헤르페스 바이러스 감염 예방에 효과가 있다.The composition of the present invention is rich in various minerals, such as ascorbic acid, becacarotene, niacin, thiamine, riboflavin, and flavonoid, and is effective in preventing allergic rhinitis or herpes virus infection.
본 발명의 조성물은 타우린을 포함하고 있어, 혈관 내 혈소판 응집 작용뿐만 아니라 각종 혈관계 질환의 예방에 효과적이다.Since the composition of the present invention contains taurine, it is effective for preventing various vascular diseases as well as for platelet aggregation in blood vessels.
본 발명의 조성물은 L-아르기닌을 포함하고 있어, 고혈압 및 협심증 치료, 항산화 기능, 면역조절, 상처치유에 효과가 있다Since the composition of the present invention contains L-arginine, it is effective in the treatment of hypertension and angina, antioxidant function, immune regulation, and wound healing.
이하, 본 발명의 일부 실시 예들을 예시적인 도면을 통해 상세하게 설명한다. 각 도면의 구성요소들에 참조부호를 부가함에 있어서, 동일한 구성요소들에 대해서는 비록 다른 도면상에 표시되더라도 가능한 한 동일한 부호를 가지도록 하고 있음에 유의해야 한다.Hereinafter, some embodiments of the present invention will be described in detail with reference to exemplary drawings. In adding reference numerals to the components of each drawing, it should be noted that the same components are given the same reference numerals as much as possible even though they are indicated on different drawings.
그리고 본 발명의 실시 예를 설명함에 있어, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 실시 예에 대한 이해를 방해한다고 판단되는 경우에는 그 상세한 설명은 생략한다. In the description of the embodiment of the present invention, if it is determined that a detailed description of a related known configuration or function interferes with the understanding of the embodiment of the present invention, the detailed description thereof will be omitted.
또한, 본 발명의 실시 예의 구성 요소를 설명하는 데 있어서, 제 1, 제 2, A, B, (a), (b) 등의 용어를 사용할 수 있다. 이러한 용어는 그 구성 요소를 다른 구성 요소와 구별하기 위한 것일 뿐, 그 용어에 의해 해당 구성 요소의 본질이나 차례 또는 순서 등이 한정되지 않는다.In addition, in describing the components of the embodiment of the present invention, terms such as first, second, A, B, (a), (b), etc. may be used. These terms are only for distinguishing the elements from other elements, and the essence, order, or order of the elements are not limited by the terms.
이하에서는 본 발명의 실시 예에 따른 콜라겐의 흡수 및 콜라겐의 합성을 촉진하는 조성물(이하, '콜라겐 조성물'이라고 함.)을 설명한다.Hereinafter, a composition for promoting collagen absorption and collagen synthesis (hereinafter referred to as a 'collagen composition') according to an embodiment of the present invention will be described.
본 발명의 콜라겐 조성물은 정제수, 콜라겐, 히알루론산, 레드비트농축액, 아세로라농축액, 타우린, 필수아미노산, L-아르기닌(L-Arginine), 복합황금추출물, 에리스리톨, 천연석류향, 효소처리스테비아, 무수구연산(Citric Acid Anhydrous), 구연산삼나트륨, 석류농축액, 세븐베리농축액을 포함할 수 있다.The collagen composition of the present invention contains purified water, collagen, hyaluronic acid, red beet concentrate, acerola concentrate, taurine, essential amino acids, L-arginine, complex golden extract, erythritol, natural pomegranate flavor, enzyme-treated stevia, anhydrous citric acid ( Citric Acid Anhydrous), trisodium citrate, pomegranate concentrate, and sevenberry concentrate.
구체적으로 본 발명의 콜라겐 조성물은, 정제수 50 내지 52 중량부, 콜라겐 26 내지 27 중량부, 히알루론산 0.4 내지 0.5중량부, 레드비트농축액 0.6 내지 0.7 중량부, 아세로라농축액 1.18 내지 1.22 중량부, 타우린 1.6 내지 1.7 중량부, 필수아미노산 0.09 내지 0.11 중량부, L-아르기닌 0.035 내지0.039 중량부, 복합황금추출물 0.19 내지 0.21 중량부, 에리스리톨 10.8 내지 11.2 중량부, 천연석류향 0.5 내지 0.7 중량부, 효소처리스테비아 0.198 내지 0.022 중량부, 무수구연산(Citric Acid Anhydrous) 1.1 내지 1.3, 구연산삼나트륨 0.08 내지 0.12 중량부, 석류농축액 2.9 내지 3.1 중량부, 세븐베리농축액 1.9 내지 2.1 중량부를 포함할 수 있다.Specifically, the collagen composition of the present invention contains 50 to 52 parts by weight of purified water, 26 to 27 parts by weight of collagen, 0.4 to 0.5 parts by weight of hyaluronic acid, 0.6 to 0.7 parts by weight of red beet concentrate, 1.18 to 1.22 parts by weight of acerola concentrate, 1.6 parts by weight of taurine. to 1.7 parts by weight, essential amino acids 0.09 to 0.11 parts by weight, L-arginine 0.035 to 0.039 parts by weight, complex golden extract 0.19 to 0.21 parts by weight, erythritol 10.8 to 11.2 parts by weight, natural pomegranate flavor 0.5 to 0.7 parts by weight, enzyme-treated stevia 0.198 to 0.022 parts by weight, citric acid anhydrous 1.1 to 1.3, trisodium citrate 0.08 to 0.12 parts by weight, pomegranate concentrate 2.9 to 3.1 parts by weight, and sevenberry concentrate 1.9 to 2.1 parts by weight.
상기 정제수는 물에 함유되어 있는 용해된 이온, 고체입자, 미생물, 유기물 및 용해된 기체류 등의 모든 불순물을 제거한 물을 의미한다.The purified water refers to water from which all impurities such as dissolved ions, solid particles, microorganisms, organic matter, and dissolved gases contained in water are removed.
상기 콜라겐은 우피, 돈피 등의 동물성 콜라겐과, 과실류, 채소류, 종자류, 견과류, 버섯류 등의 식물성 콜라겐과 해조류, 어류, 어류비늘, 어피 등의 해양성 콜라겐으로 이루어진 군에서 선택된 어느 하나 이상일 수 있다.The collagen may be any one or more selected from the group consisting of animal collagen such as cow skin and pig skin, vegetable collagen such as fruits, vegetables, seeds, nuts, and mushrooms, and marine collagen such as seaweed, fish, fish scales, and fish skin.
상기 콜라겐은, 크기가 1nm 내지 10nm로 나노화되며, 분자량이 250 Da 내지 650 Da인 콜라겐 펩타이드일 수 있다.The collagen may be a collagen peptide nanosized to have a size of 1 nm to 10 nm and a molecular weight of 250 Da to 650 Da.
바람직하게 상기 콜라겐은 평균분자량이 500 Da이고, 크기가 6nm 내지 8nm인 콜라겐 펩타이드일 수 있다.Preferably, the collagen may be a collagen peptide having an average molecular weight of 500 Da and a size of 6 nm to 8 nm.
상기 콜라겐은 KTTKS, GHK, AHK 및 이들의 혼합물 중 어느 하나 이상일 수 있다. The collagen may be any one or more of KTTKS, GHK, AHK, and mixtures thereof.
상기 히알루론산은 글루쿠론산과 N-아세틸 글루코사민의 이당중합체이고, 상기 콜라겐 조성물에서 겔을 형성하고 세균 침입을 방지할 수 있다.The hyaluronic acid is a disaccharide polymer of glucuronic acid and N-acetyl glucosamine, and can form a gel in the collagen composition and prevent bacterial invasion.
상기 레드비트농축액은 증발 공정을 통해 레드비트의 수분함량을 70% 내지 80%, 바람직하게는 76% 감소시킨 농축액이다.The red beet concentrate is a concentrate in which the water content of red beets is reduced by 70% to 80%, preferably by 76% through an evaporation process.
비타민과 철분이 풍부한 레드비트에 의해, 상기 콜라겐 조성물은 빈혈 예방에 효과가 있다. 또한 레드비트의 뿌리에는 당분, 비타민 A, 칼륨, 철, 섬유소질 및 베타시아닌이 풍부해 상기 콜라겐 조성물은 혈압을 낮추는 효과도 있다.With red beets rich in vitamins and iron, the collagen composition is effective in preventing anemia. In addition, since the root of red beet is rich in sugar, vitamin A, potassium, iron, fiber and beta cyanine, the collagen composition also has an effect of lowering blood pressure.
상기 아세로라농축액은 증발 공정을 통해 아세로라의 수분함량을 76% 내지 86%, 바람직하게는 82% 감소시킨 농축액을 의미한다The acerola concentrate means a concentrate in which the moisture content of acerola is reduced by 76% to 86%, preferably by 82% through an evaporation process
아세로라는 비타민 C, 아스코르빈산(ascorbic acid), 베카카로틴 함량이 높으며, 니아신, 티아민, 리보플라민, 플라노보이드, 칼륨 등의 각종 미네랄이 풍부하다. 이에 상기 콜라겐 조성물은 면역 증강 및 노화 방지 효과뿐 아니라, 알레르기 비염이나 헤르페스 바이러스 감염 예방에도 효과가 있다.Acerola has a high content of vitamin C, ascorbic acid, and becacarotene, and is rich in various minerals such as niacin, thiamine, riboflavin, flavonoids, and potassium. Accordingly, the collagen composition is effective not only in enhancing immunity and preventing aging, but also in preventing allergic rhinitis or herpes virus infection.
상기 타우린은 뇌의 교감 신경에 대해 억제 작용을 나타내어 혈압의 안정화 및 뇌졸중의 예방에 도움을 주고, 심장의 저칼슘 상태에서 심근의 수축력이 저하할 때 수축력을 증가시키고, 역으로 고칼슘의 경우 수축력을 감소시켜 부정맥이나 심부전에 효과가 있다. 또한, 타우린은 동맥경화, 협심증, 심근경색 등을 유발하는 저밀도 지단백질(LDL) 콜레스테롤의 생성을 억제하고, 혈관 조직에 침투되어 있는 콜레스테롤을 분해시키는 고밀도 비단백질(HDL) 콜레스테롤의 양을 증가시켜, 혈관 내 혈소판 응집 작용뿐만 아니라 각종 혈관계 질환의 예방에 효과가 있다.The taurine exerts an inhibitory action on the sympathetic nerves of the brain to help stabilize blood pressure and prevent stroke, increase the contractility when the contractility of the myocardium is lowered in a low calcium state of the heart, and conversely, increase the contractility in the case of high calcium It is effective in reducing arrhythmias and heart failure. In addition, taurine inhibits the production of low-density lipoprotein (LDL) cholesterol, which causes arteriosclerosis, angina, myocardial infarction, etc. It is effective in preventing various vascular diseases as well as platelet aggregation in blood vessels.
상기 타우린은 에틸렌 옥사이드(ethylene oxide)와 아황산수소 소듐(sodium bisulfite)사이의 반응으로 2-하이드록시에테인설폰산(2-hydroxyethanesulfonic acid, isethionic acid)을 만든 후, 가암모니아 분해 반응(aminolysis)을 통해서 타우린을 합성하거나, 아지리딘(aziridine)과 아황산 (sulfurous acid)과의 반응으로 합성하거나, 브로모에테인설폰산 염과 암모니아의 반응으로도 합성할 수도 있다. The taurine is produced by a reaction between ethylene oxide and sodium bisulfite to produce 2-hydroxyethanesulfonic acid, isethionic acid, and then through an ammoxidation reaction (aminolysis). Taurine may be synthesized, synthesized by reaction of aziridine and sulfurous acid, or may be synthesized by reaction of bromoethanesulfonic acid salt and ammonia.
상기 필수아미노산은 아이소류신(isoleucine), 류신(leucine), 라이신(lysine), 메티오닌(methionine), 페닐알라닌(phenylalanine), 트레오닌(threonine), 트립토판(tryptophan), 발린(valine)를 포함하는 것으로, 체내에서 합성되지 않거나 합성되더라도 그 양이 매우 적어 생리기능을 달성하기에 충분하지 않아서 반드시 음식에서 섭취해야만 하는 아미노산이다.The essential amino acids include isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine, in the body It is an amino acid that must be ingested from food because it is not synthesized in the body or is synthesized in a very small amount and is not sufficient to achieve physiological functions.
상기 L-아르기닌(C6H14N4O2)은 염기성이 강한 아미노산으로 수용액은 알칼리성을 되고, 비필수 아미노산이지만 요소합성반응에서 중요한 역할을 하며 오르니틴회로에 관여한다. 이러한 L-아르기닌 고혈압 및 협심증 치료, 항산화 기능, 면역조절, 상처치유에 효과가 있다.The L-arginine (C6H14N4O2) is an amino acid with strong basicity, and the aqueous solution becomes alkaline. Although it is a non-essential amino acid, it plays an important role in the urea synthesis reaction and is involved in the ornithine cycle. This L-arginine is effective in the treatment of hypertension and angina pectoris, antioxidant function, immune regulation, and wound healing.
상기 복합황금추출물은 보전제로 쓰이며, 황금농축액 36.8%, 감초농축액 27.2%, 대추농축액 10%, 황기농축액 7.2%, 텍스트린10%, 젖산 2%, 글리세린 6.8%를 포함한다.The complex golden extract is used as a preservative, and contains 36.8% of golden concentrate, 27.2% of licorice concentrate, 10% of jujube concentrate, 7.2% of Astragalus concentrate, 10% of textrin, 2% of lactic acid, and 6.8% of glycerin.
상기 에리스리톨(erythritol)은 효모인 Moniliella pollinis 또는 Trichosporonoides megachilensis 등의 발효액을 여과, 정제, 결정화, 세척, 및 건조 공정을 통해 제조될 수 있다.The erythritol (erythritol) may be prepared through filtration, purification, crystallization, washing, and drying processes of fermentation broth such as yeast Moniliella pollinis or Trichosporonoides megachilensis.
이러한 에리스리톨은 백색의 결정성분말로서 냄새가 없고, 물에 잘 녹고, 내열성이 뛰어나고 흡습성도 낮아서 결정을 쉽게 형성하는 장점이 있다. 에리스리톨의 감미도는 설탕의 70% 내지 80% 정도이며 청량한 감미를 가지고 있다. 또한 에리스리톨은 다른 감미료와 달리 체내에서 에너지원으로 이용되지 않고 대부분 배출되므로 낮은 체내 흡수율을 갖는 효과가 있다. Erythritol is a white crystalline powder, has no odor, is easily soluble in water, has excellent heat resistance, and has low hygroscopicity to easily form crystals. The sweetness of erythritol is about 70% to 80% of that of sugar and has a refreshing sweetness. Also, unlike other sweeteners, erythritol is not used as an energy source in the body and is mostly excreted, so it has the effect of having a low absorption rate in the body.
상기 효소처리스테비아(Enzymatically Modified Stevia Glucosyl Stevia)는 스테비아추출물에 α-Glucosyltransferase(α-글루코실 전이효소) 등을 작용시켜 생성된, α-글루코실스테비오시드, α-글루코실리바우디오시드 A를 정제하여 얻은 것으로서 감미의 주성분은 α-글루코실스테비오시드이다The enzyme-treated stevia (Enzymatically Modified Stevia Glucosyl Stevia) purifies α-glucosyl stevioside and α-glucosyl baudioside A, which are produced by the action of α-Glucosyltransferase (α-glucosyl transferase), etc. on the stevia extract The main component of sweetness is α-glucosylstevioside
상기 석류농축액은 증발 공정을 통해 석류의 수분함량을 72% 내지 88%, 바람직하게는 80% 감소시킨 농축액이다.The pomegranate concentrate is a concentrate in which the water content of the pomegranate is reduced by 72% to 88%, preferably by 80%, through an evaporation process.
석류는 포도당과 과당이 40%, 새콤한 맛을 내는 시트르산이 1.5% 를 차지하고, B1, B2, 나이아신 등의 수용성 비타민도 포함한다. 그리고 석류의 껍질에는 타닌, 종자에는 갱년기 장애에 좋은 천연식물성 에스트로겐을 포함한다. 석류의 열매와 껍질 모두 고혈압과, 동맥경화 예방에 좋으며, 부인병과 부스럼에 효과가 있다.Pomegranate contains 40% glucose and fructose, 1.5% citric acid, which gives a sour taste, and also contains water-soluble vitamins such as B1, B2, and niacin. And the pomegranate peel contains tannins and the seeds contain natural phytoestrogens that are good for menopausal disorders. Both the fruit and peel of the pomegranate are good for high blood pressure and arteriosclerosis prevention, and are effective for gynecological diseases and swelling.
상기 무수구연산(Anhydrous citric acid)은 유기산으로서 자연에서는 감귤 또는 레몬에서 추출될 수 있고, 감미, 방향, 살균의 효과가 있다.The anhydrous citric acid (Anhydrous citric acid) is an organic acid that can be extracted from citrus or lemon in nature, and has sweetening, aroma, and sterilizing effects.
상기 구연산삼나트륨(Trisodium Citrate)은, 무색 투명한 결정 또는 흰색의 결정성 가루로서 냄새가 없고 청량한 짠맛과 쓴맛이 있다. 그리고 상기 구연산삼나트륨은 콜라겐 조성물의 pH를 조절할 수 있다.The trisodium citrate (Trisodium Citrate) is colorless and transparent crystals or white crystalline powder without odor and has a refreshing salty and bitter taste. And the trisodium citrate can adjust the pH of the collagen composition.
상기 세븐베리농축액은, 블루베리, 크랜베리, 스트로베리, 라즈베리, 아사이베리, 블랙베리 및 블랙커런트의 농축혼합물을 의미한다.The seven berry concentrate means a concentrated mixture of blueberry, cranberry, strawberry, raspberry, acai berry, blackberry and blackcurrant.
실시예 1_ 제1콜라겐 조성물의 제조Example 1_ Preparation of first collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 히알루론산 4.6859g, 레드비트농축액 7.0235g, 아세로라농축액 12.6360g, 타우린 17.5535g, 필수아미노산 1.0530g, L-아르기닌(L-Arginine) 0.3896g, 복합황금추출물 2.1060g, 에리스리톨 115.8300g, 천연석류향 6.3180g, 효소처리스테비아 0.2106g, 무수구연산(Citric Acid Anhydrous) 12.6360g, 구연산삼나트륨 1.0530g, 석류농축액 31.5900g, 세븐베리농축액 21.0600g가 혼합된 1053g의 제1콜라겐 조성물의 제조하였다.Purified water 538.0198g, collagen 280.8351g, hyaluronic acid 4.6859g, red beet concentrate 7.0235g, acerola concentrate 12.6360g, taurine 17.5535g, essential amino acid 1.0530g, L-Arginine 0.3896g, Complex golden extract 2.1060g, erythritol 115.8300g, natural pomegranate flavor 6.3180g, enzyme-treated stevia 0.2106g, citric acid anhydrous 12.6360g, trisodium citrate 1.0530g, pomegranate concentrate 31.5900g, sevenberry concentrate 21.0600g 1053 g of the first collagen composition was prepared.
여기서 콜라겐은 어류콜라겐으로 평균분자량이 500 Da이고, 크기가 6nm 내지 8nm인 콜라겐 펩타이드를 사용하였다.Here, the collagen is fish collagen, and collagen peptides having an average molecular weight of 500 Da and a size of 6 nm to 8 nm were used.
비교예 1_ 제2콜라겐 조성물의 제조Comparative Example 1_ Preparation of the second collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 천연석류향 6.3180g, 에리스리톨 115.8300g, 석류농축액 31.5900g 가 혼합된 972.5929의 제2콜라겐 조성물의 제조하였다.A second collagen composition of 972.5929 was prepared in which 538.0198 g of purified water, 280.8351 g of collagen, 6.3180 g of natural pomegranate flavor, 115.8300 g of erythritol, and 31.5900 g of pomegranate concentrate were mixed.
여기서 콜라겐은 어류콜라겐으로 평균분자량이 500 Da이고, 크기가 6nm 내지 8nm인 콜라겐 펩타이드를 사용하였다.Here, the collagen is fish collagen, and collagen peptides having an average molecular weight of 500 Da and a size of 6 nm to 8 nm were used.
실험예 1_ 혈중 히드록시프롤린 펩타이드 측정Experimental Example 1_ Measurement of hydroxyproline peptide in blood
체중이 55kg 내지 70kg인 40대 여성, 20명을 무작위로 10 명씩, 제A그룹과 제B그룹으로 나누어 제A그룹은 실시예 1의 제1콜라겐 조성물을 10분동안 100g 섭취하고, 제B그룹은 비교예 1의 제2콜라겐 조성물을 100g을 섭취하여, 100분후 제A그룹과 제B그룹의 평균 혈중 히드록시프롤린 펩타이드를 측정하였다. 결과는 아래의 표 1과 같다.Women in their 40s, weighing 55 kg to 70 kg, were randomly divided into groups A and B, and 20 women were randomly divided into groups A and B. Group A consumed 100 g of the first collagen composition of Example 1 for 10 minutes, and group B Silver took 100 g of the second collagen composition of Comparative Example 1, and after 100 minutes, the average blood hydroxyproline peptides of groups A and B were measured. The results are shown in Table 1 below.
실시예 1의 제1콜라겐 조성물의 체내 흡수율이 비교예 1의 제2콜라겐 조성물의 체내 흡수율 보다 2.02배 높은 것으로 확인되었다.It was confirmed that the absorption rate of the first collagen composition of Example 1 was 2.02 times higher than that of the second collagen composition of Comparative Example 1.
실험예 2_ 피부 보습 측정Experimental Example 2_ Measurement of skin moisture
체중이 55kg 내지 70kg인 40대 여성, 20명을 무작위로 10 명씩, 제A그룹과 제B그룹으로 나누어 제A그룹은 실시예 1의 제1콜라겐 조성물 30g씩 30일 섭취를 하였고, 제B그룹은 비교예 1의 제2콜라겐 조성물을 30g씩 30일 섭취를 하였다. 섭취 전과 30일 동안 섭취 한 후의 피부 수분 측정을 통해 증가한 보습력을 %의 평균을 확인하였다. 피부 수분 측정은 피부수분측정기(my-808s, 스칼라 주식회사 Made in Japan)를 이용하였다. 결과는 아래의 표 2와 같다.Women in their 40s, weighing 55 kg to 70 kg, were randomly divided into 10 people each, group A and group B, and group A ingested 30 g of the first collagen composition of Example 1 for 30 days, group B The second collagen composition of Comparative Example 1 was ingested 30 g each for 30 days. The average of % of increased moisturizing power was confirmed by measuring skin moisture before ingestion and after ingestion for 30 days. Skin moisture was measured using a skin moisture meter (my-808s, Scala Co., Ltd. Made in Japan). The results are shown in Table 2 below.
실시예 1의 제1콜라겐 조성물의 피부보습효과가 비교예 1의 제2콜라겐 조성물의 피부보습효과보다 21% 높은 것을 확인하였다.It was confirmed that the skin moisturizing effect of the first collagen composition of Example 1 was 21% higher than the skin moisturizing effect of the second collagen composition of Comparative Example 1.
실험예 3_ 피부 탄력 측정Experimental Example 3_ Skin elasticity measurement
체중이 55kg 내지 70kg인 40대 여성, 20명을 무작위로 10 명씩, 제A그룹과 제B그룹으로 나누어 제A그룹은 실시예 1의 제1콜라겐 조성물 30g씩 30일 섭취를 하였고, 제B그룹은 비교예 1의 제2콜라겐 조성물을 30g씩 30일 섭취를 하였다. 섭취 전과 30일 동안 섭취 한 후의 피부 탄력 측정을 통해 증가한 탄력을 %의 평균을 확인하였다. 피부 탄력 측정은 피부탄력측정기(cutometer; SEM474, Courage+Khazaka electronic GmbH Germany)를 이용하였다. 결과는 아래의 표 3과 같다.Women in their 40s, weighing 55 kg to 70 kg, were randomly divided into 10 people each, group A and group B, and group A ingested 30 g of the first collagen composition of Example 1 for 30 days, group B The second collagen composition of Comparative Example 1 was ingested 30 g each for 30 days. The average of the percentage of increased elasticity was confirmed by measuring skin elasticity before and after ingestion for 30 days. Skin elasticity was measured using a cutometer (SEM474, Courage+Khazaka electronic GmbH Germany). The results are shown in Table 3 below.
실시예 1의 제1콜라겐 조성물의 피부탄력효과가 비교예 1의 제2콜라겐 조성물의 피부탄력효과보다 27.9% 높은 것을 확인하였다.It was confirmed that the skin elasticity effect of the first collagen composition of Example 1 was 27.9% higher than the skin elasticity effect of the second collagen composition of Comparative Example 1.
실험예 2 및 실험예 3의 결과는, 실시예 1의 제1콜라겐 조성물에 포함된 레드비트에 풍부한 규소(Si), 철분(Fe), 구리(Cu) 등의 미네랄이 콜라겐의 합성에 중요한 콜라겐 부스터(Collagen Booster)로 작용하여, 피부의 콜라겐을 증가시킨것에 기인한 것이다.The results of Experimental Example 2 and Experimental Example 3 show that minerals such as silicon (Si), iron (Fe), copper (Cu), which are abundant in red beets contained in the first collagen composition of Example 1, are important for collagen synthesis It acts as a booster (Collagen Booster), which is due to increasing collagen in the skin.
실험예 4_식품의 보관Experimental Example 4_Storage of food
실시예 1의 제1콜라겐 조성물과 비교예 1의 제2콜라겐 조성물을 이용하여 백설기, 두부, 식빵, 가래떡, 우무을 대상으로 변화 확인하였다. 식품의 변화를 확인하기 위해 실시예 1의 제1콜라겐 조성물과 비교예 1의 제2콜라겐 조성물을 각각 조라 과정의 재료 또는 조리한 음식에 1.2 내지 2.3 중량% 섞거나 뿌려 실온에서 24 시간 경과한 후, 굳는 정도, 변색 등을 육안관찰과 관능검사를 통하여 비교하였다. 결과는 아래의 표 4와 같고, A는 매우 양호, B는 양호, C는 보통, D는 불량, F는 매우 불량을 의미한다.By using the first collagen composition of Example 1 and the second collagen composition of Comparative Example 1, changes were confirmed for Baekseolgi, tofu, white bread, garaetteok, and agar. In order to confirm the change in food, the first collagen composition of Example 1 and the second collagen composition of Comparative Example 1 were mixed or sprayed with 1.2 to 2.3 wt% of each of the ingredients or cooked food of the cooking process after 24 hours at room temperature , degree of hardening, discoloration, etc. were compared through visual observation and sensory examination. The results are shown in Table 4 below, where A is very good, B is good, C is average, D is bad, and F is very poor.
표 4에서 확인할 수 있듯이, 실시예 1의 제1콜라겐 조성물은 비교예 1의 제2콜라겐 조성물 보다 식품의 보관성 개선시킴을 알 수 있다. As can be seen in Table 4, it can be seen that the first collagen composition of Example 1 improves the storage properties of food than the second collagen composition of Comparative Example 1.
비교예 2_제3콜라겐 조성물의 제조Comparative Example 2_ Preparation of the third collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 히알루론산 4.6859g, 레드비트농축액 4.0235g, 아세로라농축액 6.6360g, 타우린 17.5535g, 필수아미노산 1.0530g, L-아르기닌(L-Arginine) 0.3896g, 복합황금추출물 2.1060g, 에리스리톨 115.8300g, 천연석류향 6.3180g, 효소처리스테비아 0.2106g, 무수구연산(Citric Acid Anhydrous) 12.6360g, 구연산삼나트륨 1.0530g, 석류농축액 31.5900g, 세븐베리농축액 21.0600g가 혼합된 1044g의 제3콜라겐 조성물의 제조하였다.Purified water 538.0198g, collagen 280.8351g, hyaluronic acid 4.6859g, red beet concentrate 4.0235g, acerola concentrate 6.6360g, taurine 17.5535g, essential amino acid 1.0530g, L-Arginine 0.3896g, Complex golden extract 2.1060g, erythritol 115.8300g, natural pomegranate flavor 6.3180g, enzyme-treated stevia 0.2106g, citric acid anhydrous 12.6360g, trisodium citrate 1.0530g, pomegranate concentrate 31.5900g, sevenberry concentrate 21.0600g 1044 g of the third collagen composition was prepared.
비교예 3_제4콜라겐 조성물의 제조Comparative Example 3_Preparation of the fourth collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 히알루론산 4.6859g, 레드비트농축액 7.0235g, 아세로라농축액 12.6360g, 타우린 17.5535g, 필수아미노산 1.0530g, L-아르기닌(L-Arginine) 0.3896g, 복합황금추출물 2.1060g, 에리스리톨 110.8300g, 천연석류향 6.3180g, 효소처리스테비아 0.2106g, 무수구연산(Citric Acid Anhydrous) 12.6360g, 구연산삼나트륨 1.0530g, 석류농축액 31.5900g, 세븐베리농축액 21.0600g가 혼합된 1049g의 제4콜라겐 조성물의 제조하였다.Purified water 538.0198g, collagen 280.8351g, hyaluronic acid 4.6859g, red beet concentrate 7.0235g, acerola concentrate 12.6360g, taurine 17.5535g, essential amino acid 1.0530g, L-Arginine 0.3896g, Complex golden extract 2.1060g, erythritol 110.8300g, natural pomegranate flavor 6.3180g, enzyme-treated stevia 0.2106g, citric acid anhydrous 12.6360g, trisodium citrate 1.0530g, pomegranate concentrate 31.5900g, sevenberry concentrate 21.0600g 1049 g of a fourth collagen composition was prepared.
비교예 4_제5콜라겐 조성물의 제조Comparative Example 4_Preparation of the fifth collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 히알루론산 4.6859g, 레드비트농축액 7.0235g, 아세로라농축액 12.6360g, 타우린 17.5535g, 필수아미노산 1.0530g, L-아르기닌(L-Arginine) 0.3896g, 복합황금추출물 2.1060g, 에리스리톨 120.8300g, 천연석류향 6.3180g, 효소처리스테비아 0.2106g, 무수구연산(Citric Acid Anhydrous) 12.6360g, 구연산삼나트륨 1.0530g, 석류농축액 31.5900g, 세븐베리농축액 21.0600g가 혼합된 1058g의 제5콜라겐 조성물의 제조하였다.Purified water 538.0198g, collagen 280.8351g, hyaluronic acid 4.6859g, red beet concentrate 7.0235g, acerola concentrate 12.6360g, taurine 17.5535g, essential amino acid 1.0530g, L-Arginine 0.3896g, Complex golden extract 2.1060g, erythritol 120.8300g, natural pomegranate flavor 6.3180g, enzyme-treated stevia 0.2106g, citric acid anhydrous 12.6360g, trisodium citrate 1.0530g, pomegranate concentrate 31.5900g, sevenberry concentrate 21.0600g 1058 g of the fifth collagen composition was prepared.
비교예 5_제6콜라겐 조성물의 제조Comparative Example 5_Preparation of the sixth collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 히알루론산 4.6859g, 레드비트농축액 7.0235g, 아세로라농축액 12.6360g, 타우린 17.5535g, 필수아미노산 1.0530g, L-아르기닌(L-Arginine) 0.3896g, 복합황금추출물 2.1060g, 에리스리톨 115.8300g, 천연석류향 6.3180g, 효소처리스테비아 0.2106g, 무수구연산(Citric Acid Anhydrous) 12.6360g, 구연산삼나트륨 1.0530g, 석류농축액 21.5900g, 세븐베리농축액 16.0600g가 혼합된 1038g의 제6콜라겐 조성물의 제조하였다.Purified water 538.0198g, collagen 280.8351g, hyaluronic acid 4.6859g, red beet concentrate 7.0235g, acerola concentrate 12.6360g, taurine 17.5535g, essential amino acid 1.0530g, L-Arginine 0.3896g, Complex golden extract 2.1060g, erythritol 115.8300g, natural pomegranate flavor 6.3180g, enzyme-treated stevia 0.2106g, citric acid anhydrous 12.6360g, trisodium citrate 1.0530g, pomegranate concentrate 21.5900g, sevenberry concentrate 16.0600g 1038 g of the sixth collagen composition was prepared.
비교예 6_제7콜라겐 조성물의 제조Comparative Example 6_Preparation of the 7th collagen composition
정제수 538.0198g, 콜라겐 280.8351g, 히알루론산 4.6859g, 레드비트농축액 7.0235g, 아세로라농축액 12.6360g, 타우린 17.5535g, 필수아미노산 1.0530g, L-아르기닌(L-Arginine) 0.3896g, 복합황금추출물 1.1060g, 에리스리톨 115.8300g, 천연석류향 5.3180g, 효소처리스테비아 0.2106g, 무수구연산(Citric Acid Anhydrous) 12.6360g, 구연산삼나트륨 1.0530g, 석류농축액 31.5900g, 세븐베리농축액 21.0600g가 혼합된 1053g의 제7콜라겐 조성물의 제조하였다.Purified water 538.0198g, collagen 280.8351g, hyaluronic acid 4.6859g, red beet concentrate 7.0235g, acerola concentrate 12.6360g, taurine 17.5535g, essential amino acid 1.0530g, L-Arginine 0.3896g, Complex golden extract 1.1060g, erythritol 115.8300g, natural pomegranate flavor 5.3180g, enzyme-treated stevia 0.2106g, citric acid anhydrous 12.6360g, trisodium citrate 1.0530g, pomegranate concentrate 31.5900g, sevenberry concentrate 21.0600g 1053 g of a seventh collagen composition was prepared.
실험예 5_콜라겐의 식감Experimental Example 5_ Collagen texture
관능검사는 훈련된 관능검사 요원 20명에 의해, 단맛, 쓴맛, 신맛, 비린 맛, 향 등을 종합적으로 평가되었으며, 점수는 값이 작은 것부터 큰 것의 순서로 1점부터 5점까지이다. 결과는 아래의 표 5와 같다.The sensory test was comprehensively evaluated for sweetness, bitterness, sour taste, fishy taste, and aroma by 20 trained sensory test personnel, and the score ranges from 1 to 5 in the order from smallest to largest. The results are shown in Table 5 below.
비교예 2의 제3콜라겐 조성물 내지 비교예 6의 제7콜라겐 조성물은 단맛, 신맛, 비린 맛, 향 등이 부적절하여, 비교예 1의 제1콜라겐 조성물 보다 먹기가 불편하고, 식감이 떨어지는 것이 확인되었다.It was confirmed that the third collagen composition of Comparative Example 2 to the seventh collagen composition of Comparative Example 6 had inappropriate sweetness, sour taste, fishy taste, flavor, etc. became
이상에서, 본 발명의 실시 예를 구성하는 모든 구성 요소들이 하나로 결합하거나 결합하여 동작하는 것으로 설명되었다고 해서, 본 발명이 반드시 이러한 실시 예에 한정되는 것은 아니다. 즉, 본 발명의 목적 범위 안에서라면, 그 모든 구성 요소들이 하나 이상으로 선택적으로 결합하여 동작할 수도 있다.In the above, even though it has been described that all the components constituting the embodiment of the present invention operate by being combined or combined into one, the present invention is not necessarily limited to this embodiment. That is, within the scope of the object of the present invention, all the components may operate by selectively combining one or more.
또한, 이상에서 기재된 기술적이거나 과학적인 용어를 포함한 모든 용어들은, 다르게 정의되지 않는 한, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미가 있다. 사전에 정의된 용어와 같이 일반적으로 사용되는 용어들은 관련 기술의 문맥상의 의미와 일치하는 것으로 해석되어야 하며, 본 발명에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.In addition, all terms including technical or scientific terms described above have the same meaning as commonly understood by those of ordinary skill in the art to which the present invention belongs, unless otherwise defined. Terms commonly used, such as those defined in the dictionary, should be interpreted as being consistent with the contextual meaning of the related art, and are not interpreted in an ideal or excessively formal meaning unless explicitly defined in the present invention.
그리고 이상의 설명은 본 발명의 기술 사상을 예시적으로 설명한 것에 불과한 것으로서, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 수정 및 변형이 가능할 것이다. 따라서, 본 발명에 개시된 실시 예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시 예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.And, the above description is merely illustrative of the technical idea of the present invention, and various modifications and variations will be possible without departing from the essential characteristics of the present invention by those skilled in the art to which the present invention pertains. Therefore, the embodiments disclosed in the present invention are not intended to limit the technical spirit of the present invention, but to explain, and the scope of the technical spirit of the present invention is not limited by these embodiments. The protection scope of the present invention should be construed by the following claims, and all technical ideas within the scope equivalent thereto should be construed as being included in the scope of the present invention.
Claims (5)
Purified water, collagen, hyaluronic acid, red beet concentrate, acerola concentrate, taurine, essential amino acids, L-arginine, complex golden extract, erythritol, natural pomegranate flavor, enzyme-treated stevia, citric acid anhydrous, citric acid A collagen composition comprising trisodium acid, pomegranate concentrate, and sevenberry concentrate.
정제수 50 내지 52 중량부, 콜라겐 26 내지 27 중량부, 히알루론산 0.4 내지 0.5중량부, 레드비트농축액 0.6 내지 0.7 중량부, 아세로라농축액 1.18 내지 1.22 중량부, 타우린 1.6 내지 1.7 중량부, 필수아미노산 0.09 내지 0.11 중량부, L-아르기닌 0.035 내지0.039 중량부, 복합황금추출물 0.19 내지 0.21 중량부, 에리스리톨 10.8 내지 11.2 중량부, 천연석류향 0.5 내지 0.7 중량부, 효소처리스테비아 0.198 내지 0.022 중량부, 무수구연산(Citric Acid Anhydrous) 1.1 내지 1.3, 구연산삼나트륨 0.08 내지 0.12 중량부, 석류농축액 2.9 내지 3.1 중량부, 세븐베리농축액 1.9 내지 2.1 중량부를 포함하는 콜라겐 조성물.
The method according to claim 1,
50 to 52 parts by weight of purified water, 26 to 27 parts by weight of collagen, 0.4 to 0.5 parts by weight of hyaluronic acid, 0.6 to 0.7 parts by weight of red beet concentrate, 1.18 to 1.22 parts by weight of acerola concentrate, 1.6 to 1.7 parts by weight of taurine, 0.09 to 0.09 parts by weight of essential amino acids 0.11 parts by weight, L-arginine 0.035 to 0.039 parts by weight, complex golden extract 0.19 to 0.21 parts by weight, erythritol 10.8 to 11.2 parts by weight, natural pomegranate flavor 0.5 to 0.7 parts by weight, enzyme-treated stevia 0.198 to 0.022 parts by weight, citric anhydride (Citric acid) Acid Anhydrous) 1.1 to 1.3, 0.08 to 0.12 parts by weight of trisodium citrate, 2.9 to 3.1 parts by weight of pomegranate concentrate, and 1.9 to 2.1 parts by weight of sevenberry concentrate.
상기 콜라겐은,
크기가 1nm 내지 10nm로 나노화되며, 분자량이 250 Da 내지 650 Da인 콜라겐 펩타이드인 것을 특징으로 하는 콜라겐 조성물.
3. The method according to claim 2,
The collagen is
A collagen composition, characterized in that it is a collagen peptide having a size of 1 nm to 10 nm and a molecular weight of 250 Da to 650 Da.
상기 콜라겐은,
크기가 6nm 내지 8nm이고 평균분자량이 500 Da이고 콜라겐 펩타이드인 것을 특징으로 하는 콜라겐 조성물.
3. The method according to claim 2,
The collagen is
A collagen composition having a size of 6 nm to 8 nm, an average molecular weight of 500 Da, and a collagen peptide.
상기 콜라겐은 KTTKS, GHK, AHK 및 이들의 혼합물 중 어느 하나 이상인 콜라겐 조성물.3. The method according to claim 2,
The collagen is a collagen composition of any one or more of KTKS, GHK, AHK, and mixtures thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200069596A KR102485612B1 (en) | 2020-06-09 | 2020-06-09 | Composition for promoting absorption of collagen and synthesis of collagen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200069596A KR102485612B1 (en) | 2020-06-09 | 2020-06-09 | Composition for promoting absorption of collagen and synthesis of collagen |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210153178A true KR20210153178A (en) | 2021-12-17 |
KR102485612B1 KR102485612B1 (en) | 2023-01-09 |
Family
ID=79033732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200069596A KR102485612B1 (en) | 2020-06-09 | 2020-06-09 | Composition for promoting absorption of collagen and synthesis of collagen |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102485612B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102514459B1 (en) * | 2022-04-13 | 2023-03-24 | 최봉철 | Method of making sweet and sour pork sauce |
KR102517807B1 (en) * | 2022-07-14 | 2023-04-05 | 코리아콜라겐(주) | Drinking powder composition for boosting body-energy and Drinking powder for boosting body-energy containing the same |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005255527A (en) * | 2004-03-09 | 2005-09-22 | Matsuura Yakugyo Kk | Composition for in vivo collagen synthesis promotor |
KR20100117168A (en) * | 2009-04-24 | 2010-11-03 | 김원규 | A functional beverage comprising deep sea water, collagen, extract of japanese apricot and polydextrose as main ingredients |
KR20100127537A (en) * | 2009-05-26 | 2010-12-06 | 김원규 | A functional beverage composition comprising collagen, extract of artichoke, l-sistine, vitamin c, extract of japanese apricot and polydextrose |
KR20170005115A (en) * | 2014-05-20 | 2017-01-11 | 하이난 메이허타이 바이오테크놀로지 컴퍼니 리미티드 | Composition of natural vitamin c and fish scale collagen peptide and preparation method thereof |
KR20170093694A (en) | 2016-02-05 | 2017-08-16 | 아미코젠주식회사 | Collagen hydrolysate having high concentration of collagen tripeptide and uses thereof |
KR20180085198A (en) * | 2017-01-18 | 2018-07-26 | (주)메타사이언스 | Composition for improving skin and health food comprising the same |
KR20190085500A (en) * | 2018-01-10 | 2019-07-18 | 주식회사 지투지바이오 | Dermal filler of polycaprolactone microspheres containing collagen peptide and method for preparing the same |
KR20200030779A (en) * | 2018-09-13 | 2020-03-23 | 주식회사 리앤씨바이오 | Chelate collagen peptide and method for preparing the same |
-
2020
- 2020-06-09 KR KR1020200069596A patent/KR102485612B1/en active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005255527A (en) * | 2004-03-09 | 2005-09-22 | Matsuura Yakugyo Kk | Composition for in vivo collagen synthesis promotor |
KR20100117168A (en) * | 2009-04-24 | 2010-11-03 | 김원규 | A functional beverage comprising deep sea water, collagen, extract of japanese apricot and polydextrose as main ingredients |
KR20100127537A (en) * | 2009-05-26 | 2010-12-06 | 김원규 | A functional beverage composition comprising collagen, extract of artichoke, l-sistine, vitamin c, extract of japanese apricot and polydextrose |
KR20170005115A (en) * | 2014-05-20 | 2017-01-11 | 하이난 메이허타이 바이오테크놀로지 컴퍼니 리미티드 | Composition of natural vitamin c and fish scale collagen peptide and preparation method thereof |
KR20170093694A (en) | 2016-02-05 | 2017-08-16 | 아미코젠주식회사 | Collagen hydrolysate having high concentration of collagen tripeptide and uses thereof |
KR20180085198A (en) * | 2017-01-18 | 2018-07-26 | (주)메타사이언스 | Composition for improving skin and health food comprising the same |
KR20190085500A (en) * | 2018-01-10 | 2019-07-18 | 주식회사 지투지바이오 | Dermal filler of polycaprolactone microspheres containing collagen peptide and method for preparing the same |
KR20200030779A (en) * | 2018-09-13 | 2020-03-23 | 주식회사 리앤씨바이오 | Chelate collagen peptide and method for preparing the same |
Non-Patent Citations (2)
Title |
---|
앱솔루트 콜라겐 8.0* * |
어린콜라겐 이너씰* * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102514459B1 (en) * | 2022-04-13 | 2023-03-24 | 최봉철 | Method of making sweet and sour pork sauce |
KR102517807B1 (en) * | 2022-07-14 | 2023-04-05 | 코리아콜라겐(주) | Drinking powder composition for boosting body-energy and Drinking powder for boosting body-energy containing the same |
Also Published As
Publication number | Publication date |
---|---|
KR102485612B1 (en) | 2023-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102239121B1 (en) | Sugar-free pineapple extract, method for producing the extract, and application of the extract | |
JP4470212B2 (en) | Skin improver | |
WO2011036786A1 (en) | Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient | |
JP5018171B2 (en) | Plant-derived activator and extracellular matrix production promoter | |
US9687438B2 (en) | Method for enhancing collagen secretion and preventing cutaneous aging using chenopodium formosanum extract | |
JP6670166B2 (en) | Cosmetics | |
KR101768806B1 (en) | Composition comprising a fermented Araliaceae plant for anti-inflammation or anti-cancer | |
CN111990558A (en) | Whitening and antioxidant compound fruit drink with good absorption effect and preparation method thereof | |
JPWO2007148737A1 (en) | Method for preparing plant extract, plant extract and use thereof | |
JPH11106336A (en) | Maillard reaction inhibitor | |
KR102485612B1 (en) | Composition for promoting absorption of collagen and synthesis of collagen | |
CN103478811A (en) | Blueberry-blackberry mixed juice beverage and preparation method thereof | |
JP2007204423A (en) | Method for producing extract of bamboo grass and use of the extract | |
US6899891B2 (en) | Nutritional composition, methods of producing said composition and methods of using said composition | |
CN115399413A (en) | Whitening and anti-aging composition, preparation process and application thereof | |
CN111903880A (en) | Anti-saccharification and anti-oxidation composition, preparation method and application thereof | |
EP3357352A1 (en) | Composition with amino acids | |
JP2009292756A (en) | Polyamine-containing stress-mitigating agent | |
KR102322269B1 (en) | Calcium-collagen peptide chelate complex and method for preparing the same | |
JP2003137801A (en) | Collagen production promoter, collagenase inhibitor, fibroblast cell-propagating agent, skin cosmetic material and food or beverage for cosmetic use | |
JPWO2005042555A1 (en) | Tyrosinase activity inhibitor and facial blood flow improving agent | |
KR102240111B1 (en) | Cosmetic composition for moisturizing skin and improving skin wrinkles containing nano collagen peptide chelate mineral | |
JP5578160B2 (en) | Plant-derived activator and extracellular matrix production promoter | |
JP2006061038A (en) | Enzyme-treated royal jelly-containing health drink | |
EP2052731B1 (en) | Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genusacacia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |